← Open Payments lookup

LAURA BLUE: Open Payments

NPI 1154925535 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,246 in 51 payments from 10 companies in 2025. Trend: 2023 $99 · 2024 $455 · 2025 $1,246

Food & beverage: $1,246
CompanyPaymentsAmount
Alkermes, Inc.18$378
ABBVIE INC.8$184
Otsuka America Pharmaceutical, Inc.5$180
Neurocrine BioSciences, Inc.6$154
Janssen Pharmaceuticals, Inc4$100
Lundbeck LLC3$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
E.R. Squibb & Sons, L.L.C.2$49
Takeda Pharmaceuticals U.S.A., Inc.2$43
Vanda Pharmaceuticals Inc.1$29

Products named: ARISTADA, VRAYLAR, INGREZZA, ABILIFY MAINTENA, LYBALVI, REXULTI, INVEGA SUSTENNA, CAPLYTA.

Industry payments across HI — which companies pay providers there.